If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts.
Most bio's get acquired on P2 readouts, if results are strong early here. Will management look for an early exit or are they wanting to take to market?
Just came across IXC from another stock @JabraD posts on. Looking forward to doing some DD in depth.
Some great posts from you @CatalystDriven will start with your threads above. Nice to see an understanding of valuing biotech's in development phase.
Has IXC provided any information on estimated peak sales revenue?
Fundamental Analysis Discussion Only (IXC Thread), page-32
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable